Atukuri Dorababu
Karnatak University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Atukuri Dorababu.
European Journal of Medicinal Chemistry | 2013
Pramod P. Kattimani; Ravindra R. Kamble; Mahadevappa Y. Kariduraganavar; Atukuri Dorababu; Raveendra K. Hunnur
A series of novel 2-(4-chlorophenyl)-5-methyl-4-(2-amine/oxy-ethyl)-2,4-dihydro-[1,2,4]triazol-3-one (5a-t) were synthesized and in vitro anticancerous action of the resulting compounds was studied against NCI-60 Human Tumor Cell Line at a single high dose (10(-5) M) concentration for primary cytotoxicity assay. Among the tested compounds (5a-e, 5g-h, 5k, 5p), the compound 5g (NSC: 761736/1) was further evaluated for five dose criteria at five different minimal concentrations against the full panel of 60 human tumor cell lines which exhibited activity against Leukemia (GI50: 1.10 μM), Non-Small Cell Lung Cancer (GI50: 1.00 μM), Renal Cancer (GI50: 1.00 μM), Colon Cancer (GI50: 1.66 μM), CNS Cancer (GI50: 1.36 μM), Melanoma (GI50: 1.82 μM), Ovarian Cancer (GI50: 1.64 μM) and Breast Cancer (GI50: 1.69 μM).
Archiv Der Pharmazie | 2013
Tegginamath Gireesh; Ravindra R. Kamble; Pramod P. Kattimani; Atukuri Dorababu; Maraswamy Manikantha; Joy Harris Hoskeri
A novel series of Biginelli 2–3 (a and b) and Biginelli‐like compounds 4–7 (a and b) were synthesized from 3‐aryl‐4‐formylsydnone 1 (a and b). Since the crystal structure of hyaluronidase was unavailable, the human hyaluronidase protein structure was used as template and homology modeling was performed, validated by Ramachandran plots and subjected to docking studies along with in vitro anti‐inflammatory activity assessment against hyaluronidase. Compounds 2–3 (a and b) exhibited potent enzyme inhibition.
Journal of Chemistry | 2013
Tasneem Taj; Ravindra R. Kamble; Atukuri Dorababu; Gangadhar Y. Meti
In the present investigation, 1,2,4-triazole appended to pyrazoline and pyrazole rings (4a–g) using N-arylsydnone as synthon was prepared. The title compounds were subjected to Osiris property explorer for the oral bioavailability to analyze their drug likeness and drug score. Further, the compounds were subjected to the antimicrobial activity and analyzed the IC 50 and MIC values.
Journal of Heterocyclic Chemistry | 2017
Pramod P. Kattimani; Ravindra R. Kamble; Atukuri Dorababu; Raveendra K. Hunnur; Atulkumar A. Kamble; H. C. Devarajegowda
Letters in Organic Chemistry | 2013
Atukuri Dorababu; Ravindra R. Kamble; Pramod P. Kattimani
Archive | 2017
Pramod P. Kattimani; Ravindra R. Kamble; Atukuri Dorababu; K. H. Raveendra; Atulkumar A. Kamble; H. C. Devarajegowda
Arabian Journal of Chemistry | 2017
Raveendra K. Hunnur; Ravindra R. Kamble; Atukuri Dorababu; B. Sunil Kumar; Chinna Bathula
Letters in Organic Chemistry | 2014
Atukuri Dorababu; Ravindra R. Kamble; Pramod P. Kattimani; Mahadevappa Y. Kariduraganavar; Atulkumar A. Kamble
Letters in Organic Chemistry | 2015
Atukuri Dorababu; Ravindra R. Kamble; H. C. Devarajegowda; Gangadhar Y. Meti
ChemInform | 2015
Tegginamath Gireesh; Ravindra R. Kamble; Atukuri Dorababu; Shilpa M. Somagond; P. C. Jabin; Vidya Nagar